Find a Doctor or Practice Location

Are you a referring physician?
I am searching for a
Reset Form
Mariusz A. Wasik, MD

Mariusz A. Wasik, MD Physician

Dr. Wasik is employed by Penn Medicine.

No Patient Satisfaction Reviews
Why not?

There is no publicly available rating for this medical professional for one of the following reasons:

  1. He or she is not employed by Penn Medicine.
  2. He or she does not see patients.
  3. He or she sees patients but has not yet received the minimum 30 patient satisfaction reviews in the past 12 months, ensuring that the rating is statistically reliable and a true reflection of patient satisfaction.

Clinical Specialties


  • Pathology and Laboratory Medicine

Programs & Centers:

Board Certification:

  • Hematology, 1993
  • Pathology - Anatomic Pathology, 1991

Clinical Expertise:

  • Blood Cancer
  • Bone Marrow Diseases
  • Bone Marrow Transplant
  • Cancer Screening and Diagnostics

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: Wroclaw Academy of Medicine
Fellowship: Boston Medical Center (Formerly Boston City Hospital)
Fellowship: Dana-Farber Cancer Institute
Residency: Boston Medical Center (Formerly Boston City Hospital)
Fellowship: Beth Israel Deaconess Medical Center

Hospital Affiliation

Dr. Wasik is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.


Selected Publications:

Levine BL, Svoboda J, Nasta SD, Porter D, Chong EA, Lacey SF, Mahnke YD, Melenhorst JJ, Chew A, Shah GD, Hasskar J, Wasik MA, Landsburg DJ, Mato A, Garfall AL, Frey NV, Shaw PA, Marcucci KT, Shea J, McConville H, Manvar N, O'Rourke DM, Lamontagne A, Bersenev A, Zheng Z, Schuster SJ, June CH: Chimeric antigen receptor modified T cells directed against CD19 (CTL019) induce clinical responses in patients with relapsed or refractory CD19+ lymphomas. Cytotherapy 17 (6): S13,2015.

Li Y, Chitnis N, Nakagawa H, Kita Y, Natsugoe S, Yang Y, Li Z, Wasik M, Klein-Szanto AJ, Rustgi AK, Diehl JA: PRMT5 is required for lymphomagenesis triggered by multiple oncogenic drivers. Cancer Discov. 5 (3): 288-303,2015.

Willerslev-Olsen A, Litvinov IV, Fredholm SM, Petersen DL, Sibbesen NA, Gniadecki R, Zhang Q, Bonefeld CM, Wasik MA, Geisler C, Zhou Y, Woetmann A, Sasseville D, Krejsgaard T, Odum N : IL-15 and IL-17F are differentially regulated and expressed in mycosis fungoides (MF). Cell Cycle 13 (8): 1306-1312,2014.

Fredholm S, Gjerdrum LM, Willerslev-Olsen A, Petersen DL, Nielsen IO, Kauczok CS, Wobser M, Ralfkiaer U, Bonefeld CM, Wasik MA, Krejsgaard T, Geisler C, Ralfkiaer E, Gniadecki R, Woetmann A, Odum N: STAT3 Activation and Infiltration of Eosinophil Granulocytes in Mycosis Fungoides. Anticancer Res. 34 (10): 5277-5286,2014.

Krejsgaard T, Willerslev-Olsen A, Lindahl LM, Bonefeld CM, Koralov SB, Geisler C, Wasik MA, Gniadecki R, Kilian M, Iversen L, Woetmann A, Odum N: Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulation. Blood 124 (5): 761-770,2014.

Hameed UF, Lim J, Zhang Q, Wasik MA, Yang D, Swaminathan K: Transcriptional repressor domain of MBD1 is intrinsically disordered and interacts with its binding partners in a selective manner. Sci Rep. 4 : 4896,2014.

Luskin MR, Roy DB, Wasik MA, Loren AW: Development of lymphomas containing Epstein-Barr virus following therapy with hyper-CVAD regimen. Clin Lymphoma Myeloma Leuk. 14 (2): e55-58,2014.

Moti N, Malcolm T, Hamoudi R, Mian S, Garland G, Hook CE, Burke GA, Wasik MA, Merkel O, Kenner L, Laurenti E, Dick JE, Turner SD: Anaplastic large cell lymphoma-propagating cells are detectable by side population analysis and possess an expression profile reflective of a primitive origin. Oncogene 34 (14): 1843-1852,2015.

Zhang Q, Wang HY, Wei F, Liu X, Paterson JC, Roy D, Mihova D, Woetmann A, Ptasznik A, Odum N, Schuster SJ, Marafioti T, Riley JL, Wasik MA: Cutaneous T cell lymphoma expresses immunosuppressive CD80 (B7-1) cell surface protein in a STAT5-dependent manner. J Immunol. 192 (6): 2913-2919,2014.

Stonecypher M, Yan Z, Wasik MA, LiVolsi V: Intravascular Large B-cell Lymphoma presenting as a thyroid mass. Endocrine Pathol. 25 (3): 359-360,2014.

Ralfkiaer U, Lindahl LM, Litman T, Gjerdrum LM, Ahler CB, Gniadecki R, Marstrand T, Fredholm S, Iversen L, Wasik MA, Bonefeld CM, Geisler C, Krejsgaard T, Glue C, Ropke MA, Woetmann A, Skov L, Gronaek K, Odum N: MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T cell lymphoma. Anticancer Res. 34 (12): 7207-7217,2014.

Marzec M, Halasa K, Liu X, Wang HY, Cheng M, Baldwin D, Tobias JW, Schuster SJ, Woetmann A, Zhang Q, Turner SD, Odum N, Wasik MA: Malignant transformation of CD4+ T lymphocytes mediated by oncogenic kinase NPM/ALK recapitulates IL-2-induced cell signaling and gene expression reprogramming. J Immunol. 191 (12): 6200-6207,2013.

Wasik MA, Jimenez GS, Weisenburger DD: Targeting CD30 in malignant tissues: challenges in detection and clinical applications. Pathobiology 80 (5): 252-258,2013 .

Yao S, Cheng M, Zhang Q, Wasik M, Kelsh R, Winkler C: Anaplastic lymphoma kinase is required for neurogenesis in the developing zebrafish central nervous system of zebrafish. PLoS One 8 (5): e63757,2013.

Lee SC, Marzec M, Liu X, Wehrli S, Kantekure K, Ragunath PN, Nelson DS, Delikatny EJ, Glickson JD, Wasik MA: Decreased lactate concentration and glycolytic enzyme expression reflect inhibition of mTOR signal transduction pathway in B-cell lymphoma. NMR Biomed. 26 (1): 106-114,2013.

Related Links